On January 13-14, 2021, the expert team of the Ningxia Drug Administration inspected Qiyuan Pharmaceutical's vitamin C API for compliance with the Good Manufacturing Practice (GMP).

On February 9, Qiyuan Pharmaceutical received the "Notice on the Compliance Inspection Results of Ningxia Qiyuan Pharmaceutical Co., Ltd. Drug Production Quality Management Regulations" issued by the Ningxia Drug Administration, and the notification recognized Qiyuan Pharmaceuticals Vitamin C The API meets the requirements of the "Good Manufacturing Practice for Drugs" (revised in 2010).

Qiyuan Pharmaceutical's vitamin C raw materials successfully passed the compliance inspection of drug production quality management regulations, ensuring the compliance of the company's vitamin C raw materials as drugs sold at home and abroad.

Yan Tao